What is the current recommended treatment for community acquired pneumonia?
Antibiotic therapy for community-acquired pneumonia should always be selected with patient characteristics, place of acquisition, and severity of disease in mind. With concerns about antimicrobial overuse, health care costs, and bacterial resistance increasing, many experts feel that therapy should always follow confirmation of the diagnosis of pneumonia and should always be accompanied by a diligent effort to identify an etiologic agent (see “National Guidelines”). When a specific pathogen is identified, pathogen-specific therapy can be employed (Table 8). When a pathogen is yet to be identified, empiric therapy is employed. Multiple expert panels have authored recommendations for empiric pneumonia therapy, most prominently the Infectious Disease Society of America (IDSA) and the American Thoracic Society (ATS) (Table 9). Aspiration Pneumonia Clindamycin is preferred over penicillin for the treatment of community-acquired aspiration pneumonia because of its superiority in the treatmen
